At a glance
- Originator Tanabe Seiyaku
- Developer Nonindustrial source; Tanabe Seiyaku
- Class Anti-ischaemics
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Myocardial infarction; Reperfusion injury
Most Recent Events
- 14 Apr 2000 New profile
- 14 Apr 2000 Preclinical development for Myocardial infarction in Japan (Unknown route)
- 14 Apr 2000 Preclinical development for Reperfusion injury in Japan (Unknown route)